Comparison of simplified parametric methods for visual interpretation of 11C-pittsburgh compound-B PET images

Journal of Nuclear Medicine

Volumn 55, Issue 8, 2014, Pages 1305-1307

  Zwan, Marissa D ^a,b   Ossenkoppele, Rik ^a,b   Tolboom, Nelleke ^b   Beunders, Alexandra J M ^b   Kloet, Reina W ^b   Adriaanse, Sofie M ^a,b   Boellaard, Ronald ^b   Windhorst, Albert D ^b   Raijmakers, Pieter ^b   Adams, Human ^b   Lammertsma, Adriaan A ^b   Scheltens, Philip ^a   Van Der Flier, Wiesje M ^a,b   Van Berckel, Bart N M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Positron emission tomography; Visual assessment

Indexed keywords

AMYLOID; PITTSBURGH COMPOUND B; BENZOTHIAZOLE DERIVATIVE; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE;

AGED; ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NONDISPLACEABLE BINDING POTENTIAL; PHARMACOLOGICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; STANDARDIZED UPTAKE VALUE; STANDARDIZED UPTAKE VALUE RATIO; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DEMENTIA; DIAGNOSTIC USE; METABOLISM; OBSERVER VARIATION; PROCEDURES; SCINTISCANNING;

AGED; AMYLOID; BENZOTHIAZOLES; DEMENTIA; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY;

EID: 84905457478     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.114.139121     Document Type: Article

References (20)

1. Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31:1275-1283.
2. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306-319.
3. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology. 2007;68:1205-1212.
4. Ossenkoppele R, Prins ND, Pijnenburg YA, et al. Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimers Dement. 2013;9:414-421.
5. 11C-PIB PET study. Neurology. 2009;73:754-760.
6. Koivunen J, Scheinin N, Virta JR, et al. Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology. 2011;76:1085-1090.
7. 11C]PIB studies. Neuroimage. 2008;42:76-86.
8. 18F-FDG PET for detection of Alzheimer's disease. J Nucl Med. 2007;48:547-552.
9. 11C]PIB PET in patients with cognitive impairment. Eur J Nucl Med Mol Imaging. 2010;37:1141-1147.
10. 18F] FDDNP PET images. J Neurol Neurosurg Psychiatry. 2010;81:882-884.
11. 18F-FDDNP PET. J Nucl Med. 2009;50:191-197.
12. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269.
13. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456-2477.
14. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863-1872.
15. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54(suppl 5):S15-S19.
16. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1-9.
17. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies-report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
18. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, Dekosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review)-report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-1142.
19. Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med. 1997;38:1614-1623.
20. Rowe CC, Ng S, Ackermann U, et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007;68:1718-1725.